|
1
|
Lyman GH, Giuliano AE, Somerfield MR,
Benson AB III, Bodurka DC, Burstein HJ, Cochran AJ, Cody HS III,
Edge SB, Galper S, et al: American Society of Clinical Oncology:
American Society of Clinical Oncology guideline recommendations for
sentinel lymph node biopsy in early-stage breast cancer. J Clin
Oncol. 23:7703–7720. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Giuliano AE, Hunt KK, Ballman KV, Beitsch
PD, Whitworth PW, Blumencranz PW, Leitch AM, Saha S, McCall LM and
Morrow M: Axillary dissection vs. no axillary dissection in women
with invasive breast cancer and sentinel node metastasis, A
randomized clinical trial. JAMA. 305:569–579. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Galimberti V, Cole BF, Zurrida S, Viale G,
Luini A, Veronesi P, Baratella P, Chifu C, Sargenti M, Intra M, et
al: Axillary dissection versus no axillary dissection in patients
with sentinel-node micrometastases (IBCSG 23-01): A phase 3
randomised controlled trial. Lancet Oncol. 14:297–305. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Donker M, van Tienhoven G, Straver ME,
Meijnen P, van de Velde CJ, Mansel RE, Cataliotti L, Westenberg AH,
Klinkenbijl JH, Orzalesi L, et al: Radiotherapy or surgery of the
axilla after a positive sentinel node in breast cancer (EORTC
10981-22023 AMAROS): A randomised, multicentre, open-label, phase 3
non-inferiority trial. Lancet Oncol. 15:1303–1310. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Goldhirsch A, Wood WC, Coates AS, Gelber
RD, Thürlimann B and Senn HJ: Panel members: Strategies for
subtypes - dealing with the diversity of breast, cancer. Highlights
of the St. Histopathology. Ann Oncol. 22:1736–1747. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Overgaard M, Nielsen HM and Overgaard J:
Is the benefit of postmastectomy irradiation limited to patients
with four or more positive nodes, as recommended in international
consensus reports? A subgroup analysis of the DBCG 82 b&c
randomized trials. Radiother Oncol. 82:247–253. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Recht A, Edge SB, Solin LJ, Robinson DS,
Estabrook A, Fine RE, Fleming GF, Formenti S, Hudis C, Kirshner JJ,
et al: Postmastectomy radiotherapy: Clinical practice guidelines of
the American Society of Clinical Oncology. J Clin Oncol.
19:1539–1569. 2001.PubMed/NCBI
|
|
8
|
Meretoja TJ, Audisio RA, Heikkilä PS, Bori
R, Sejben I, Regitnig P, Luschin-Ebengreuth G, Zgajnar J, Perhavec
A, Gazic B, et al: International multicenter tool to predict the
risk of four or more tumor-positive axillary lymph nodes in breast
cancer patients with sentinel node macrometastases. Breast Cancer
Res Treat. 138:817–827. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Katz A, Smith BL, Golshan M, Niemierko A,
Kobayashi W, Raad RA, Kelada A, Rizk L, Wong JS, Bellon JR, et al:
Nomogram for the prediction of having four or more involved nodes
for sentinel lymph node-positive breast cancer. J Clin Oncol.
26:2093–2098. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chagpar AB, Scoggins CR, Martin RC II,
Cook EF, McCurry T, Mizuguchi N, Paris KJ, Carlson DJ, Laidley AL,
El-Eid SE, et al: Predicting patients at low probability of
requiring postmastectomy radiation therapy. Ann Surg Oncol.
14:670–677. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Rivers AK, Griffith KA, Hunt KK, Degnim
AC, Sabel MS, Diehl KM, Cimmino VM, Chang AE, Lucas PC and Newman
LA: Clinicopathologic features associated with having four or more
metastatic axillary nodes in breast cancer patients with a positive
sentinel lymph node. Ann Surg Oncol. 13:36–44. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sagara Y, Ohi Y, Matsukata A, Yotsumoto D,
Baba S, Tamada S and Sagara Y, Matsuyama Y, Ando M, Rai Y and
Sagara Y: Clinical application of the one-step nucleic acid
amplification method to detect sentinel lymph node metastasis in
breast cancer. Breast Cancer. 20:181–186. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Espinosa-Bravo M, Sansano I, Pérez-Hoyos
S, Ramos M, Sancho M, Xercavins J, Rubio IT and Peg V: Prediction
of non-sentinel lymph node metastasis in early breast cancer by
assessing total tumoral load in the sentinel lymph node by
molecular assay. Eur J Surg Oncol. 39:766–773. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ohi Y, Umekita Y, Sagara Y, Rai Y,
Yotsumoto D, Matsukata A, Baba S, Tamada S, Matsuyama Y, Ando M, et
al: Whole sentinel lymph node analysis by a molecular assay
predicts axillary node status in breast cancer. Br J Cancer.
107:1239–1243. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Osako T, Iwase T, Kimura K, Horii R and
Akiyama F: Sentinel node tumour burden quantified based on
cytokeratin 19 mRNA copy number predicts non-sentinel node
metastases in breast cancer, Molecular whole-node analysis of all
removed nodes. Eur J Cancer. 49:1187–1195. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Peg V, Espinosa-Bravo M, Vieites B,
Vilardell F, Antúnez JR, de Salas MS, Delgado-Sánchez JJ, Pinto W,
Gozalbo F, Petit A, et al: Intraoperative molecular analysis of
total tumor load in sentinel lymph node: A new predictor of
axillary status in early breast cancer patients. Breast Cancer Res
Treat. 139:87–93. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sobin LH, Gospodarowicz MK and Wittekind
C: UICC International Union Against Cancer TMN Classification of
Malignant Tumours (7th). Hoboken, NJ: Wiley-Blackwell. 181–193.
2009.
|
|
18
|
Tsujimoto M, Nakabayashi K, Yoshidome K,
Kaneko T, Iwase T, Akiyama F, Kato Y, Tsuda H, Ueda S, Sato K, et
al: One-step nucleic acid amplification for intraoperative
detection of lymph node metastasis in breast cancer patients. Clin
Cancer Res. 13:4807–4816. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
van la Parra RF, Peer PG, Ernst MF and
Bosscha K: Meta-analysis of predictive factors for non-sentinel
lymph node metastases in breast cancer patients with a positive
SLN. Eur J Surg Oncol. 37:290–299. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chu KU, Turner RR, Hansen NM, Brennan MB,
Bilchik A and Giuliano AE: Do all patients with sentinel node
metastasis from breast carcinoma need complete axillary node
dissection? Ann Surg. 229:536–541. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Reynolds C, Mick R, Donohue JH, Grant CS,
Farley DR, Callans LS, Orel SG, Keeney GL, Lawton TJ and Czerniecki
BJ: Sentinel lymph node biopsy with metastasis, Can axillary
dissection be avoided in some patients with breast cancer? J Clin
Oncol. 17:1720–1726. 1999.PubMed/NCBI
|
|
22
|
Yi M, Giordano SH, Meric-Bernstam F,
Mittendorf EA, Kuerer HM, Hwang RF, Bedrosian I, Rourke L and Hunt
KK: Trends in and outcomes from sentinel lymph node biopsy (SLNB)
alone vs. SLNB with axillary lymph node dissection for
node-positive breast cancer patients, Experience from the SEER
database. Ann Surg Oncol. 17((Suppl 3)): S343–S351. 2010.
View Article : Google Scholar
|
|
23
|
Bilimoria KY, Bentrem DJ, Hansen NM,
Bethke KP, Rademaker AW, Ko CY, Winchester DP and Winchester DJ:
Comparison of sentinel lymph node biopsy alone and completion
axillary lymph node dissection for node-positive breast cancer. J
Clin Oncol. 27:2946–2953. 2009. View Article : Google Scholar : PubMed/NCBI
|
